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EDITORIAL COMMENT
To Stent or Not to Stent—That
Is the Question*
Michael H. Sketch, Sr., MD, FACC
Omaha, Nebraska
Occasionally, one comes across an article in which one or
more of its authors questions or challenges a concept or
conclusion that they had previously held or championed.
This speaks highly of our profession and our colleagues.
Cappelletti et al.’s (1) report in this issue of JACC is such an
article. It challenges us to modify our present indications for
the use of stents.
See page 1484
There is no question that the introduction of stents and
their subsequent refinement have enabled us to safely and
successfully apply transluminal coronary artery therapy to a
significantly broader spectrum of clinical and anatomic
situations as compared with balloon angioplasty alone, but
do we deploy stents too frequently? Are there situations in
which stents are either unnecessary or not indicated? Are
there situations in which the cost of stents cannot be
justified?
Because of its design, it would not be appropriate to use
the findings of this study to argue either for or against the
routine use of stents. However, some might be tempted to
use the reported findings to support a policy discouraging
the use of stents in the presence of coronary artery dissec-
tions. I would caution against this. The authors’ study group
is small (49 unstented patients) and limited to a single
institution. Therapy was not randomized, and the study was
retrospective. Nevertheless, I agree with the authors in that
in the presence a type A and B dissections in a relatively
tortuous vessel #2.5 mm in diameter, it appears that
stenting may not be indicated. Also, I agree with the authors
in that their findings suggest that in the presence of
dissections that are not associated with flow limitation and
that are in vessels #3 mm in diameter, the use of endovas-
cular prostheses should be evaluated carefully. However,
because the majority of the dissections the authors reported
were types A and B, the results can only be inferred to apply
to patients with these lesions.
Cappelletti et al.’s (1) study supports the contention that
type A and B dissections are relatively benign complications
of percutaneous transluminal coronary angioplasty. When
faced with these dissections, cardiologists have only two
therapeutic options: 1) deployment stents, or 2) prolonged
observation in the catheterization laboratory with or with-
out prolonged balloon inflations. Hence, necessarily, one
must ask which option is associated with the most appro-
priate balance between therapeutic benefit and cost? This
question remains unanswered. Further, in clinical practice,
how often would these options be associated with the need
to return patients to the catheterization laboratory for
emergent or semi-emergent follow-up, even though the
authors report no such need? Again this question remains
unanswered.
Finally, although the authors report no clinically adverse
effects in the 38% of patients who had angiographically
visible dissections at six-month follow-up, one must be
concerned about long-term prognosis—for instance, the
subsequent incidence of myocardial infarction.
Despite its limitations and the fact that it failed to
provide answers to the questions I have posed, Cappelletti et
al.’s (1) study is important in that it reminds us that as
custodians of our patients’ health, we must continually seek
to refine our indications for therapeutic options, or, in this
instance, to paraphrase Shakespeare: To stent or not to stent,
that is the question?
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